Advanced Accelerator Applications SA, a French manufacturer of nuclear medicine products, increased its sales of diagnostic products in 2013 while advancing its lead radiopharmaceutical, Lutathera, for patients with neuroendocrine tumours. ---Subscribe to MedNous to access this article--- Company News
